Laura Pighi

Dr. Laura Pighi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Elisa DaneseElisa Danese
Elisa Danese
Claudia PionaClaudia Piona
Claudia Piona
MRMariateresa Rizza
Mariateresa Rizza
ETElena Tiziani
Elena Tiziani
LPLaura Pighi
Laura Pighi
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
Background: The early detection of type 1 diabetes (T1D) through screening for major islet autoantibodies is receiving increasing attention as a public health strategy, exemplified by the recent implementation of a pilot pediatric screening program in Italy. The transition from research-based screening to large-scale population initiatives needs automated and standardized assays that are capable of processing extensive sample volumes. Hence, this study aimed to evaluate the analytical performance and comparability of a fully automated chemiluminescence immunoassay (CLIA) compared to a conventional enzyme-linked immunosorbent assay (ELISA) for the detection of three classes of major islet antibodies—anti-GAD (GADA), anti-IA-2 (IA-2A), and anti-ZnT8 (ZnT8A). Methods: A total of 104 serum specimens were analyzed for each autoantibody using both ELISA (RSR and Medyzim, DYNES, DSX) and CLIA (MAGLUMI 800). Assay precision and linearity were assessed through intra-assay variability studies and dilution protocols. Methods agreement was evaluated with Passing–Bablok regression, Spearman’s correlation, Bland–Altman analysis, and Cohen’s kappa statistics. Results: The CLIA showed good precision and excellent linearity across clinically relevant concentration ranges of all islet antibodies. Correlation coefficients and categorical agreement between CLIA and ELISA were high (r > 0.96 and Cohen’s kappa >0.8 for all), with ZnT8A exhibiting the highest concordance. However, proportional biases were found, as CLIA systematically underestimated GADA and ZnT8A levels, while overestimated IA-2A compared to the ELISA. Conclusions: The CLIA displayed satisfactory precision and agreement with ELISA for GADA, IA-2A, and ZnT8A detection. Our findings support the use of these automated immunoassays in large-scale population initiatives for diagnosing T1D, but we also highlight the need for further efforts to achieve better inter-assay harmonization.

13 September 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
LPLaura Pighi
Laura Pighi
Camilla MattiuzziCamilla Mattiuzzi
Camilla Mattiuzzi
Laboratory medicine has undergone a deep and multifaceted revolution in the course of human history, in both organizational and technical terms. Over the past century, there has been a growing recognition of the need to centralize numerous diagnostic activities, often similar or identical but located in different clinical departments, into a common environment (i.e., the medical laboratory service), followed by a progressive centralization of tests from smaller laboratories into larger diagnostic facilities. Nevertheless, the numerous technological advances that emerged at the beginning of the new millennium have helped to create a new testing culture characterized by a countervailing trend of decentralization of some tests closer to patients and caregivers. The forces that have driven this (centripetal) counter-revolution essentially include a few key concepts, namely “home testing”, “portable or even wearable devices” and “remote patient monitoring”. By their very nature, laboratory medical services and remote patient testing/monitoring are not contradictory, but may well coexist, with the choice of one or the other depending on the demographic and clinical characteristics of the patient, the type of analytical procedure and the logistics and local organization of the care system. Therefore, this article aims to provide a general overview of patient self-testing, with a particular focus on portable and wearable (including implantable) devices.

27 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Elisa DaneseElisa Danese
Elisa Danese
Claudia PionaClaudia Piona
Claudia Piona
MRMariateresa Rizza
Mariateresa Rizza
ETElena Tiziani
Elena Tiziani
LPLaura Pighi
Laura Pighi
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
Background: Early detection of type 1 diabetes (T1D) through major islet antibodies screening is gaining momentum as public health strategy, with Italy recently implementing a pilot pediatric screening program. The transition from research-based screening to large-scale population initiatives needs automated and standardized assays capable of processing extensive sample volumes. This study was hence aimed at evaluating the analytical performance and comparability of a fully-automated chemiluminescence immunoassay (CLIA) compared to a conventional enzyme-linked immunosorbent assay (ELISA) for detection of three classes of major islet antibodies anti-GAD (GADA), anti-IA-2 (IA-2A) and anti-ZnT8 (ZnT8A). Methods: A total of 104 serum specimens were analyzed for each autoantibody using both ELISA (DYNES, DSX) and CLIA (MAGLUMI 800). Assay precision and linearity were assessed through intra-assay variability studies and dilution protocols. Methods agreement was evaluated with Passing-Bablok regression, Spearman’s correlation, Bland-Altman analysis and Cohen’s kappa statistics. Results: CLIA showed good precision and excellent linearity across clinically relevant concentration ranges of all islet antibodies. Correlation coefficients and categorical agreement between CLIA and ELISA were high (r>0.96 and Cohen’s kappa >0.8 for all), with ZnT8A exhibiting the highest concordance. However, proportional biases were found, as CLIA systematically underestimated GADA and ZnT8A levels, while overestimated IA-2A compared with ELISA. Conclusions: CLIA assays displayed satisfactory precision and agreement with ELISA for GADA, IA-2A and ZnT8A detection. Our findings support the use of these automated immunoassay in large-scale population initiatives for diagnosing TD1, but we also highlight the need for further efforts to achieve better inter-assay harmonization.

2 September 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MBMarco Benati
Marco Benati
LPLaura Pighi
Laura Pighi
EPElisa Paviati
Elisa Paviati
SVSara Visconti
Sara Visconti
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
Gian Luca SalvagnoGian Luca Salvagno
Gian Luca Salvagno
Background and aims: The aim of this study was to investigate the possible preanalytical effect of incomplete filling of blood tubes on molecular biology assays. Materials and methods: The study population consisted of 13 healthy volunteers from whom 11 mL of whole blood was collected and then distributed in different volumes (1.5, 3.0, and 6.0 mL, respectively) into three 6.0 mL spray-dried and evacuated K2EDTA blood tubes. Automated RNA extraction was performed using the Maxwell® CSC RNA Blood Kit. DNA was extracted with a MagCorePlusII, with concomitant measurement of glyceralde-hyde-3-phosphate dehydrogenase (GAPDH) gene expression. The nucleic acid concentration was calculated using the NanoDrop 1000 spectrophotometer, and purity was assessed using A260/280 and A260/230 absorbance ratios. Results: The RNA concentration was higher in the tubes filled with 1.5 and 3.0 mL of blood than in the reference 6 mL filled tube. The RNA 260/280 and RNA 260/230 ratios did not differ significantly between the differently filled blood tubes. The DNA concentration remained constant in the differently filled tubes. Compared to the 6.0 mL reference filled tube, the 1.5 mL and 3.0 mL filled blood tubes displayed a lower DNA 260/280 nm ratio. The DNA 260/230 ratio did not differ significantly in any of the variously filled tubes. Compared to the 6.0 mL reference filled blood tube, the 1.5 mL and 3.0 mL filled blood tubes showed a significant increase in the GAPDHcycle threshold. Conclusions: Our results suggest that underfilling of K2EDTA blood tubes may be a modest but analytically significant source of bias in molecular biology testing.

Verified
Journal Article
Open access
PDF file
DNDavide Negrini
Davide Negrini
LPLaura Pighi
Laura Pighi
SMSimone Mignolli
Simone Mignolli
Gian Luca SalvagnoGian Luca Salvagno
Gian Luca Salvagno
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
Background/Objectives: Iron deficiency remains a prevalent condition, needing specific laboratory tests for diagnosis. This study aimed to evaluate whether routine complete blood cell count (CBC) parameters can be used within a machine learning framework to predict low ferritin and low transferrin saturation, used as biochemical markers of altered iron status, potentially supporting more targeted laboratory test utilization. Methods: In this single-center retrospective outpatient study, we analyzed 32,437 records from subjects undergoing both complete blood cell count and iron metabolism testing between 2023 and 2026. Low ferritin and low transferrin saturation were defined using sex-specific thresholds. Low ferritin was present in 14,344 subjects (44.2%), whereas low transferrin saturation was present in 7791 subjects (24.0%). After cleaning data and excluding incomplete records, demographic variables and CBC indices were tested as potential predictors. The dataset was split into training and test sets with stratified sampling. Multiple supervised machine learning models, including logistic regression, decision tree, random forest, XGBoost, support vector machine, k-nearest neighbors, and Naive Bayes, were trained. Hyperparameter tuning and model selection were performed using repeated stratified 10-fold cross-validation, optimizing the area under the curve (AUC). Model performance was assessed by AUC, sensitivity, and specificity, and validated on an independent test set. Results: All models showed predictive capability for low ferritin and low transferrin saturation using CBC parameters alone. Ensemble methods, especially random forest and XGBoost, reached the best performance (AUC values of 0.80–0.87 for ferritin and 0.85–0.96 for transferrin saturation). Sensitivity and specificity were balanced, supporting clinical screening applicability. Results were maintained across validation and confirmed in the test set. Prediction of transferrin saturation showed slightly higher accuracy than ferritin. Feature importance analysis identified mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red blood cell distribution width (RDW) as key predictors. Conclusions: CBC-based machine learning models may help identify subjects with low ferritin or low transferrin saturation, supporting subsequent targeted assessment of iron status.

3 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Elisa DaneseElisa Danese
Elisa Danese
CTCantor Tarperi
Cantor Tarperi
MRMauro Di Ruvo
Mauro Di Ruvo
MTMarco Tosi
Marco Tosi
LPLaura Pighi
Laura Pighi
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
Background/Objectives: Circulating nucleosomes containing H3.1 represent a distinct fraction of extracellular chromatin. Although strenuous exercise is known to increase circulating extracellular chromatin components, it remains unclear whether H3.1-containing nucleosomes also respond to moderate physiological stress and whether this response varies with the underlying biological condition. Methods: Sixteen healthy subjects and 13 subjects with cancer completed a standardized 5 km walking exercise. Venous blood samples were collected immediately before and after exercise, and circulating H3.1-containing nucleosomes were quantified in K2-EDTA plasma with an automated immunoassay. Within-group and between-group comparisons were performed using non-parametric tests. Relative exercise-induced changes and age-adjusted analyses were evaluated as sensitivity analyses. Results: Circulating H3.1-containing nucleosome concentrations increased significantly after exercise in both healthy subjects (p < 0.0001) and those with cancer (p = 0.001). Cancer patients displayed higher baseline concentrations (p = 0.0056), whereas post-exercise concentrations were comparable between groups (p = 0.840). The absolute exercise-induced increase was significantly higher in healthy subjects (p = 0.028). This difference was confirmed when the response was expressed relative to individual baseline concentrations (median increase: 124.7% [IQR 63.9–191.5%] vs. 36.5% [20.6–42.0%]; p = 0.0009) and persisted after age adjustment (p = 0.0046). Conclusions: Circulating H3.1-containing nucleosomes respond to moderate aerobic exercise, with distinct patterns in healthy subjects and those with cancer. These preliminary findings support further investigation of H3.1-containing nucleosomal chromatin as a dynamic marker of the biological response to exercise.